Photodiagnosis and Photodynamic Therapy
Volume 3, Issue 2 , Pages 134-137, June 2006

Photodynamic therapy in the management of a patient with Gorlin syndrome (naevoid basal cell carcinoma syndrome)

Dept of Clinical Oncology, Christie Hospital (NHS) Trust, Manchester M20 4BX, UK

published online 24 May 2006.

Summary 

Gorlin syndrome (naevoid basal cell carcinoma syndrome) is a genetically linked disorder characterized by the development of multiple basal cell carcinomas (BCCs) throughout life. Cumulative surgery, cryotherapy and other conventional interventions can result in significant disfigurement by middle age. Radiotherapy is contra-indicated because the mutated gene underlying the syndrome, ‘PTCH’, increases sensitivity to ionising radiation, so there is significant likelihood of inducing further tumours in and around the irradiated area. Photodynamic therapy offers a non-invasive treatment option for patients with this condition, with the added advantage of causing minimal scarring.

Keywords: Photodynamic therapy, Basal cell carcinoma, PDT, Gorlin syndrome, Naevoid basal cell carcinoma syndrome, Photofrin

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1572-1000(06)00059-7

doi:10.1016/j.pdpdt.2006.03.011

Photodiagnosis and Photodynamic Therapy
Volume 3, Issue 2 , Pages 134-137, June 2006